Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Super Micro Computer
SMCI
$25.8B
| $6.26M | ﹤0.01% |
1,552,090
+1,173,350
| +310% | +$5.35M |
|
3302
Zillow
ZG
$7.91B
| $6.26M | ﹤0.01% |
196,754
+89,764
| +84% | +$3.54M |
|
3303
PUT
iShares MSCI India ETF
INDA
$6.56B
| $6.26M | ﹤0.01% |
158,900
-51,800
| -25% | -$2.18M |
|
3304
Jefferies Financial Group
JEF
$12.7B
| $6.25M | ﹤0.01% |
236,895
-123,095
| -34% | -$3.64M |
|
3305
PUT
CoStar Group
CSGP
$13.1B
| $6.25M | ﹤0.01% |
103,500
-33,100
| -24% | -$2M |
|
3306
Lamar Advertising Co
LAMR
$15.8B
| $6.25M | ﹤0.01% |
71,066
-469,725
| -87% | -$47.7M |
|
|
FAAS
3307
DELISTED
DigiAsia
FAAS
| $6.25M | ﹤0.01% |
625,008
-624,994
| -50% | -$6.23M |
|
3308
PUT
Chemours
CC
$2.39B
| $6.24M | ﹤0.01% |
194,900
-53,500
| -22% | -$1.97M |
|
3309
ProKidney
PROK
$278M
| $6.24M | ﹤0.01% |
627,066
-516,263
| -45% | -$5.1M |
|
3310
Angi Inc
ANGI
$191M
| $6.24M | ﹤0.01% |
136,228
+2,177
| +2% | +$107K |
|
3311
PUT
NRG Energy
NRG
$26.5B
| $6.24M | ﹤0.01% |
163,400
+41,900
| +34% | +$1.71M |
|
3312
PUT
Wendy's
WEN
$1.65B
| $6.23M | ﹤0.01% |
329,900
+132,300
| +67% | +$2.51M |
|
|
NLSN
3313
DELISTED
Nielsen Holdings plc
NLSN
| $6.22M | ﹤0.01% |
268,029
-529,139
| -66% | -$13.5M |
|
3314
Global Net Lease
GNL
$2.03B
| $6.22M | ﹤0.01% |
439,154
+28,778
| +7% | +$411K |
|
3315
Walt Disney
DIS
$184B
| $6.22M | ﹤0.01% |
65,853
-32,649
| -33% | -$3.62M |
|
|
CGC
3316
CALL
Canopy Growth
CGC
$431M
| $6.21M | ﹤0.01% |
218,040
-3,480
| -2% | -$181K |
|
3317
Nu Skin
NUS
$234M
| $6.21M | ﹤0.01% |
143,452
+52,971
| +59% | +$2.43M |
|
3318
CALL
NOV
NOV
$7.54B
| $6.21M | ﹤0.01% |
367,000
-15,000
| -4% | -$282K |
|
|
3319
NOV
NOV
$7.54B
| $6.21M | ﹤0.01% |
366,962
-78,487
| -18% | -$1.48M |
|
3320
Expensify
EXFY
$210M
| $6.2M | ﹤0.01% |
348,431
-99,752
| -22% | -$1.77M |
|
3321
Lakeland Financial Corp
LKFN
$1.55B
| $6.2M | ﹤0.01% |
93,340
+23,467
| +34% | +$1.67M |
|
3322
PUT
iShares MSCI South Korea ETF
EWY
$27.8B
| $6.2M | ﹤0.01% |
106,500
+43,200
| +68% | +$2.83M |
|
3323
Cousins Properties
CUZ
$4.89B
| $6.19M | ﹤0.01% |
211,875
+173,401
| +451% | +$6M |
|
3324
Hanover Insurance
THG
$7.84B
| $6.19M | ﹤0.01% |
42,315
-74,670
| -64% | -$11M |
|
|
WIRE
3325
CALL
DELISTED
Encore Wire Corp
WIRE
| $6.18M | ﹤0.01% |
59,500
-18,700
| -24% | -$2.21M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.